Sciclone Pharmaceuticals, Inc. (SCLN) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts SCLN Hot Sheet
Price: $11.15 --0%
Financial Fact:
Sales and marketing: 13.32M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Sales and marketing: 13.32M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLN) reported Q1 EPS of $0.10, $0.02 better than the analyst estimate of $0.08. Revenue for the quarter came in at $26.6 million versus the consensus estimate of $32.2 million.
For earnings history and earnings-related data on Sciclone Pharmaceuticals, Inc. (SCLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
